129 related articles for article (PubMed ID: 10360674)
1. Clonality analysis suggests that early-onset acute lymphoblastic leukaemia is of single-cell origin and implies no major role for germ cell mutations in parents.
Rinaldi F; Mairs RJ; Wheldon TE; Katz F; Chessells JM; Gibson BE
Br J Cancer; 1999 May; 80(5-6):909-13. PubMed ID: 10360674
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
3. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Shu XO; Perentesis JP; Wen W; Buckley JD; Boyle E; Ross JA; Robison LL;
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1230-5. PubMed ID: 15247135
[TBL] [Abstract][Full Text] [Related]
4. Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR.
Lal A; Kwan E; Haber M; Norris MD; Marshall GM
Mol Cell Probes; 2001 Apr; 15(2):99-103. PubMed ID: 11292328
[TBL] [Abstract][Full Text] [Related]
5. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
[TBL] [Abstract][Full Text] [Related]
6. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
[TBL] [Abstract][Full Text] [Related]
9. JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukaemia.
MacKenzie J; Perry J; Ford AM; Jarrett RF; Greaves M
Br J Cancer; 1999 Nov; 81(5):898-9. PubMed ID: 10555765
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
12. Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR.
Kerst G; Kreyenberg H; Roth C; Well C; Dietz K; Coustan-Smith E; Campana D; Koscielniak E; Niemeyer C; Schlegel PG; Müller I; Niethammer D; Bader P
Br J Haematol; 2005 Mar; 128(6):774-82. PubMed ID: 15755280
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
Matsushita C; Yang Y; Takeuchi S; Matsushita M; Van Dongen JJ; Szczepanski T; Bartram CR; Seo H; Koeffler HP; Taguchi H
Oncol Rep; 2004 Jul; 12(1):97-9. PubMed ID: 15201966
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).
Varon R; Reis A; Henze G; von Einsiedel HG; Sperling K; Seeger K
Cancer Res; 2001 May; 61(9):3570-2. PubMed ID: 11325820
[TBL] [Abstract][Full Text] [Related]
15. Alternative models for early onset of childhood leukaemia.
Wheldon TE; Mairs RJ; Barrett A; Wheldon EG; Gibson BE
Br J Cancer Suppl; 1992 Aug; 18():S13-9. PubMed ID: 1503920
[TBL] [Abstract][Full Text] [Related]
16. Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.
Clayton RN; Pfeifer M; Atkinson AB; Belchetz P; Wass JA; Kyrodimou E; Vanderpump M; Simpson D; Bicknell J; Farrell WE
Clin Cancer Res; 2000 Oct; 6(10):3973-82. PubMed ID: 11051246
[TBL] [Abstract][Full Text] [Related]
17. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
18. Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients.
Olesen LH; Clausen N; Dimitrijevic A; Kerndrup G; Kjeldsen E; Hokland P
Br J Haematol; 2004 Oct; 127(1):59-66. PubMed ID: 15384978
[TBL] [Abstract][Full Text] [Related]
19. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia.
Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M
Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
